News

  • 20 August 2019

    Mateon and PointR to merge into AI-driven oncology firm

    Immuno-oncology company Mateon Therapeutics has signed a definitive agreement to merge with PointR Data, a computer and artificial intelligence (AI) company, to form an AI-driven firm focused on cancer treatment.

Close
Close
Close

Go Top